Comerica Bank’s Enzo Biochem, Inc. ENZ Stock Holding History

Comerica Bank’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-36,577	Closed	-$76K	–	2619
2013 Q2	$76K	Buy	+36,577	New	+$80.7K	﹤0.01%	2221

Other funds holding ENZ

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

CCM

Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCT

Chemung Canal Trust Elmira, New York $541M AUM 32.42% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Comerica Bank's ENZ Position: Q3 2013 in Review

Comerica Bank sold out of Enzo Biochem, Inc. (ENZ) in Q3 2013, closing a stake of 36,577 shares — an estimated $76K sold.

Comerica Bank first reported a position in ENZ in Q2 2013 and held it in 1 quarter. The position peaked at $76K in Q2 2013. 52 funds tracked by Wall St. Rank hold ENZ as of Q3 2013.

Comerica Bank reported no remaining Enzo Biochem, Inc. position as of Q3 2013 after selling out during the quarter.
Comerica Bank sold 36,577 Enzo Biochem, Inc. shares in Q3 2013, an estimated $76K.
Comerica Bank first reported a position in Enzo Biochem, Inc. in Q2 2013 and held it in 1 quarter.
Comerica Bank's Enzo Biochem, Inc. position peaked at $76K in Q2 2013.
52 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2013.

Based on Comerica Bank's 13F filing for Q3 2013, filed 12 Nov 2013.